All GLP-1 Journey Guides
235 hand-edited guides organized by topic, category, and medication. New guides go live every day.
monitor_heartLiving with other conditions · 6 guides
PCOS, T2D, sleep apnea, heart, kidney, fatty liver.
GLP-1s and Fatty Liver (NAFLD/MASH): Promising Evidence
GLP-1s for fatty liver: what the ESSENCE trial showed for MASH, how semaglutide and tirzepatide compare, and what's still off-label.
Read guidearrow_forwardGLP-1s and Heart Disease: Cardiovascular Protection in 2026
GLP-1s reduce major cardiac events independent of weight loss. The SELECT trial, Wegovy's FDA cardiovascular indication, and what we still don't know about tirzepatide.
Read guidearrow_forwardGLP-1s and Kidney Disease: When They Help and When They Don't
GLP-1s slow kidney disease progression in T2D — the FLOW trial showed a 24% reduction in kidney events. Who benefits, who shouldn't take them, and dehydration risks.
Read guidearrow_forwardGLP-1s and Sleep Apnea: Zepbound's New Indication Explained
Zepbound is FDA-approved for obstructive sleep apnea in adults with obesity. What SURMOUNT-OSA showed, who qualifies, and how it fits with CPAP.
Read guidearrow_forwardGLP-1s with Type 2 Diabetes: How They Work for Both
How GLP-1s treat type 2 diabetes: A1c reductions, weight loss, hypoglycemia risk, and the difference between Ozempic, Mounjaro, and their weight-loss siblings.
Read guidearrow_forwardGLP-1s for PCOS: How They Help (and the Limits)
GLP-1s for PCOS: how they target insulin resistance, weight, and ovulation, what the evidence actually shows, and where they fall short.
Read guidearrow_forward